Correcting Dysregulated Immune Response by AIC in Various Autoimmune Diseases

Regulated increases in cytosolic and organellar Ca2+ concentrations in lymphocytes control complex and crucial effector functions such as metabolism, proliferation, differentiation, antibody and cytokine secretion, cytotoxicity, apoptosis, and numerous gene transcriptions. AIC therapy restores calcium signaling, which is of paramount importance to proper immune function.

Introduction

Understanding the molecular bases of Ca2+ and autoimmune diseases is essential. AIC therapy crucially regulates calcium channels, supporting the immune system's regulation of autoimmune diseases. The power of AIC therapy lies in its sensitivity to calcium exchange and its impact on ER calcium release, effectively modulating immune receptor responses. Precise intracellular calcium transfer and modulation by AIC therapy is critical in managing autoimmune conditions, including rheumatoid arthritis and inflammatory/allergic disorders. This approach allows for the efficient use of necessary calcium without promoting bone resorption.

Figure 1
Cellular calcium (Ca²⁺) regulation highlights entry through receptor-mediated, transient receptor potential, and voltage-gated channels and efflux via plasma membrane ATPase and exchangers. Depletion of ER calcium stores activates STIM1, which then activates CRAC channels, facilitating additional calcium influx. Key interactions include phospholipase C activation and inositol triphosphate receptor-mediated calcium release.

Revolutionizing Autoimmune Treatment with AIC Therapy

Altered Ca2+ regulation in lymphocytes contributes to autoimmune diseases, inflammatory conditions, and immunodeficiency syndromes. T-cell dysfunction can lead to systemic autoimmunity seen in common rheumatic diseases. Antigen receptor engagement reduces intracellular Ca2+ during an immune response, while store-operated calcium entry (SOCE) raises it. Enhancing SOCE through AIC therapy helps manage autoimmune diseases by boosting the immune regulation in a controlled manner. By improving SOCE, AIC therapy ensures adequate calcium influx into immune cells, which is crucial for their activation and function. This enhancement normalizes the dysregulated immune responses seen in autoimmune diseases, leading to better regulation of immune cell activity and reducing the severity of autoimmune attacks on the body's own tissues.

Figure 2
Calcium signaling is essential in T cell activation. NAADP triggers the initial release of calcium from the endoplasmic reticulum, which is then amplified by inositol-1,4,5-trisphosphate (IP3), ensuring sustained calcium signaling. This prolonged calcium signaling is crucial for the proper functioning of T cells.

Clinical Case 1

This case involves a 41-year-old female patient with atopic dermatitis. In early 2022, she exhibited severe skin inflammation and irritation on her neck, arm, and face. After undergoing AIC Therapy from January 2023, her face displays a remarkable reduction in redness, scaling, and overall skin irritation. These results highlight the effectiveness of AIC Therapy in managing and alleviating the symptoms of atopic dermatitis.

Clinical Case 2

A 25-year-old woman from Jakarta was diagnosed with psoriasis in August 2017. After six months of AIC Therapy, her symptoms significantly improved. She experienced a healing reaction during the first week of treatment, but her condition started to get better soon after. Once her symptoms had considerably reduced, she switched to a maintenance dosage. The scars from psoriasis took more than a year to disappear, showing the effectiveness of AIC Therapy in managing and relieving psoriasis symptoms.

Clinical Case 3

This case involves Ms. H. T. Kim, a female patient from South Korea who has suffered from eczema since childhood. She began taking MaraGen twice daily for one year. Despite experiencing healing reactions for the first three to six months, she continued the treatment. Her persistence resulted in significant improvement in her skin condition, demonstrating the effectiveness of MaraGen in managing long-term eczema.

AIC Therapy: A New Frontier in Rheumatoid Arthritis Treatment and Beyond.

Integrating AIC Therapy into autoimmune treatment plans offers a promising approach to managing and alleviating symptoms.

Calcium (Ca2+)-calcineurin-T cell interactions play a significant role in the pathogenesis of rheumatoid arthritis (RA). Elevated intracellular Ca2+ levels activate the Ca2+-calcineurin pathway in osteoclasts, promoting osteoclastogenesis. AIC Therapy significantly decreases the formation of bone-degrading cells and effectively relieves RA symptoms by correcting dysregulated calcium storage and cellular responses. This is crucial, as insufficient external ionic calcium may compel the body to deplete bone calcium, damaging bone health. Therefore, AIC Therapy serves as a vital calcium source, preserving bone reserves and aiding in the treatment of autoimmune diseases.

AIC Therapy restores calcium signaling, which is essential for immune cell function and regulation and shows promising results in treating conditions like atopic dermatitis, psoriasis, rheumatoid arthritis, and other inflammatory disorders, representing a significant step forward in autoimmune disease management.

Figure 3
Calcium (Ca2+) regulation in cells involves controlled entry through specific channels and proteins and its release from internal stores like the endoplasmic reticulum. This process is balanced by mechanisms that remove calcium from the cell to maintain optimal levels.

We offer free 25-minute Zoom consultation sessions for practitioners wanting to know more about AIC Therapy.

Join our community today and get instant access to cutting-edge research on AIC Therapy for your patient’s treatments.

We would be pleased if you visit our website for more detailed information specific to each disease.

Thank you for reading.

Server Bozdogan MD, PhD.

ACRI Research Director.

Don’t Miss the Upcoming AANP 2024 Conference In Chicago

Dr. Ryan Bradley, ND, MPH, will speak about AIC therapy and calcitonin. (July 11th, 1:30-2:30 pm)

The Roles of Calcitonin and Osteocalcin in Systemic lonic Calcium Balance and Signaling.